Blue7

Blue7 is a Singapore based impact investor. We directly support passionate entrepreneurs with bold and effective solutions that address underserved needs in livelihood resilience, community development and environmental protection. We also invest in global impact funds as well as ESG scored listed equities. ​Blue7 deploys a variety of financial instruments ranging from debt to equity. Working with partners in Asia and beyond, our portfolio operates to create long term value for society and the environment.

Juanita FU

Co-Founder

MA Hui Hsing

Co-Founder

3 past transactions

AMILI

Series A in 2022
AMILI develops diagnostic tests, predictive algorithms, and microbiome-modifying interventions. They also offer probiotics and diagnostic tests based on their own microbiome database. They also provide faecal microbiota transplants to aid in the treatment of bacterial infections.

Smarter Health

Series A in 2022
Smarter Health provides a trusted infrastructure for data exchange between key stakeholders of the healthcare ecosystem. Smarter Health's “SIMPLIFY, STANDARDISE and SYSTEMISE” approach supports the delivery and payment of healthcare services in an efficient and effective manner. They believe that healthcare should be accessible, affordable, and accountable. The Smarter Health team consists of experienced senior executives from established healthcare and insurance institutions in Asia.

Pintek

Series A in 2021
Pintek is a financial technology company aiming to democratise access to education in Indonesia through affordable and flexible credit.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.